Strategies to therapeutically modulate cytokine action

WJ Leonard, JX Lin - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted or membrane-presented molecules that mediate broad cellular
functions, including development, differentiation, growth and survival. Accordingly, the …

Next-generation regulatory T cell therapy

LMR Ferreira, YD Muller, JA Bluestone… - Nature reviews Drug …, 2019 - nature.com
Regulatory T cells (Treg cells) are a small subset of immune cells that are dedicated to
curbing excessive immune activation and maintaining immune homeostasis. Accordingly …

The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

S Dong, KJ Hiam-Galvez, CT Mowery, KC Herold… - JCI …, 2021 - pmc.ncbi.nlm.nih.gov
BACKGROUND A previous phase I study showed that the infusion of autologous Tregs
expanded ex vivo into patients with recent-onset type 1 diabetes (T1D) had an excellent …

[HTML][HTML] Treg enhancing therapies to treat autoimmune diseases

PJ Eggenhuizen, BH Ng, JD Ooi - International journal of molecular …, 2020 - mdpi.com
Regulatory T cells (Tregs) are a small yet critical subset of CD4+ T cells, which have the role
of maintaining immune homeostasis by, for example, regulating self-tolerance, tumor …

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

M Rosenzwajg, R Lorenzon, P Cacoub… - Annals of the rheumatic …, 2019 - Elsevier
Abstract Objective Regulatory T cells (Tregs) prevent autoimmunity and control
inflammation. Consequently, any autoimmune or inflammatory disease reveals a Treg …

IL-2-based approaches to Treg enhancement

F Harris, YA Berdugo, T Tree - Clinical and experimental …, 2023 - academic.oup.com
Immune homeostasis is heavily dependent on the action of regulatory T cells (Tregs) which
act to suppress the activation of many immune cell types including autoreactive conventional …

Regulatory T cells: the many faces of Foxp3

P Georgiev, LM Charbonnier, TA Chatila - Journal of clinical immunology, 2019 - Springer
Regulatory T (Treg) cells expressing the transcription factor forkhead box P3 (Foxp3) play a
requisite role in the maintenance of immunological homeostasis and prevention of …

Low-dose IL-2 therapy in autoimmune and rheumatic diseases

H Graßhoff, S Comdühr, LR Monne, A Müller… - Frontiers in …, 2021 - frontiersin.org
Regulatory T cells (Treg) are crucial for the maintenance of peripheral tolerance and for the
control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is …

N-glycosylation and inflammation; the not-so-sweet relation

B Radovani, I Gudelj - Frontiers in immunology, 2022 - frontiersin.org
Chronic inflammation is the main feature of many long-term inflammatory diseases such as
autoimmune diseases, metabolic disorders, and cancer. There is a growing number of …

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

D Klatzmann, AK Abbas - Nature Reviews Immunology, 2015 - nature.com
Depletion of regulatory T (TReg) cells in otherwise healthy individuals leads to multi-organ
autoimmune disease and inflammation. This indicates that in a normal immune system …